Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide.
Gurnari C, Piciocchi A, Soddu S, Bonanni F, Scalzulli E, Niscola P, Di Veroli A, Piccioni AL, Piedimonte M, Maiorana G, Salutari P, Cicconi L, Santopietro M, Gumenyuk S, Sarlo C, Fenu S, Tafuri A, Latagliata R, Fianchi L, Criscuolo M, Maciejewski JP, Maurillo L, Buccisano F, Breccia M, Voso MT.
Gurnari C, et al. Among authors: soddu s.
Blood Cancer J. 2022 Sep 7;12(9):132. doi: 10.1038/s41408-022-00724-3.
Blood Cancer J. 2022.
PMID: 36071048
Free PMC article.
No abstract available.